Type of Hypersensitivity Reactions Related to Vaccination
Vaccinations primarily cause Type I (immediate) hypersensitivity reactions mediated by IgE antibodies, and less commonly Type IV (delayed-type) hypersensitivity reactions. 1
Type I Hypersensitivity (Immediate Reactions)
Type I reactions are IgE-mediated and occur within minutes to hours (typically within the first 4 hours) after vaccine administration 1, 2. These reactions include:
- Mild manifestations: Urticaria (hives), localized angioedema
- Moderate manifestations: Generalized urticaria, swelling of mouth and throat, wheezing
- Severe manifestations: Anaphylaxis with multiple organ system involvement, including respiratory distress, hypotension, shock, and decreased consciousness 1
The incidence is extremely rare, estimated at approximately 1.5 cases per 1 million vaccine doses administered 1. The most common culprits triggering these reactions are:
- Residual egg protein in vaccines grown in embryonated eggs (influenza, yellow fever vaccines) 1, 3, 4
- Gelatin used as a stabilizer 5
- Polyethylene glycol (PEG) and polysorbate 80 in COVID-19 vaccines 6
- Antibiotics (particularly neomycin) 5
- Latex (from vial stoppers) 7
Clinical Approach to Egg Allergy
For patients with documented IgE-mediated egg hypersensitivity, asking if they can eat eggs without adverse effects is a reasonable screening method 1. Those with severe reactions to eggs (hives, lip/tongue swelling, acute respiratory distress, or collapse) require physician consultation and potentially allergy evaluation before vaccination 3, 4. However, most egg-allergic patients can safely receive vaccines after appropriate evaluation 5.
Type IV Hypersensitivity (Delayed-Type Reactions)
Type IV reactions are cell-mediated and occur hours to days after vaccination 1, 8. These include:
- Local delayed reactions: Contact dermatitis-like responses at injection sites
- "COVID arm": Delayed large local skin lesions occurring days after COVID-19 vaccination 9
- Thimerosal hypersensitivity: Typically manifests as local, delayed-type reactions rather than systemic responses 1, 8
Important caveat: Although thimerosal can induce Type IV hypersensitivity on patch testing, the majority of patients do not develop clinical reactions when thimerosal is administered as a vaccine component 1. When reactions occur, they are typically mild and localized 3, 8.
Other Vaccine-Associated Reactions (Not Classic Hypersensitivity)
While not fitting traditional hypersensitivity classifications, several immune-mediated reactions deserve mention:
- Autoimmune phenomena: Vasculitis, lupus erythematosus, immune thrombocytopenia following COVID-19 vaccination 9
- Viral reactivation: Herpes zoster reactivation 9, 10
- Oculorespiratory syndrome (ORS): Self-limited reaction with ocular and respiratory symptoms occurring 2-24 hours post-vaccination 1
Critical Management Points
All vaccine providers must:
- Be familiar with emergency protocols and certified in cardiopulmonary resuscitation 1
- Have immediate access to intramuscular epinephrine for anaphylaxis treatment
- Observe patients for at least 15-30 minutes post-vaccination (longer for high-risk individuals)
- Measure serum tryptase within 1-4 hours after moderate-to-severe immediate reactions to confirm hypersensitivity 11
Common pitfall: Do not confuse coincidental respiratory illness occurring after vaccination with vaccine-induced hypersensitivity 3, 4. The vaccine contains only noninfectious material and cannot cause influenza or other infections.
For patients with previous hypersensitivity reactions, referral to an allergist for skin testing with alternative vaccine formulations is safer and more effective than empiric premedication 11.